University of Maryland, Greenebaum Cancer Center — Baltimore, Maryland

University of Maryland, Greenebaum Cancer Center is a clinical research site located in Baltimore, Maryland, United States 21201.

Crixeo Health Trust Score: 83/100 (GOOD). This profile has not yet been claimed by the site owner.

University of Maryland, Greenebaum Cancer Center has participated in 19 clinical trials with 1 currently active.

Therapeutic areas: Hepatocellular Cancer, AFP Expressing Tumors, UC (Urothelial Cancer).

Sponsors: Adaptimmune, Incyte Corporation, BioInvent International AB.

Sponsor Feasibility Report

Trust Score: 83/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Maryland, Greenebaum Cancer Center?

University of Maryland, Greenebaum Cancer Center has a Crixeo Trust Score of 83/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Maryland, Greenebaum Cancer Center conducted?

University of Maryland, Greenebaum Cancer Center has 19 clinical trials on record, with 1 currently active. Their work covers Hepatocellular Cancer, AFP Expressing Tumors, UC (Urothelial Cancer).

Is University of Maryland, Greenebaum Cancer Center accredited by Crixeo Health?

Yes — University of Maryland, Greenebaum Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about University of Maryland, Greenebaum Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.